Synopsys Inc

SNPS

Synopsys Inc. (SNPS) is a leading provider of software, intellectual property, and services used in the design and verification of electronic systems and semiconductors. Founded in 1986, the company is known for its electronic design automation (EDA) tools that help semiconductor and integrated circuit manufacturers streamline their development processes and improve product performance. Synopsys serves a broad range of industries, including consumer electronics, automotive, and telecommunications.

$509.47 -0.97 (-0.19%)
🚫 Synopsys Inc does not pay dividends

Company News

Launch Azimuth Analysis Software Market Research Report 2026: Airbus, Lockheed Martin, and Northrop Grumman are Increasingly Focusing on Real-time Trajectory Simulations & Advanced Integration
GlobeNewswire Inc. • Researchandmarkets.Com • January 9, 2026

The launch azimuth analysis software market is experiencing rapid growth, expanding from $1.13 billion in 2024 to an anticipated $1.84 billion by 2029 (10.2% CAGR). Growth is driven by rising satellite mega-constellations, commercial space exploration, and AI-driven trajectory optimization. Key players like Airbus, Lockheed Martin, and Northrop G...

SNPS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc • December 30, 2025

A class action lawsuit has been filed against Synopsys, Inc. alleging that the company made materially false and misleading statements regarding its business operations. The complaint claims Synopsys failed to disclose that its increased focus on AI customers requiring additional customization was deteriorating the economics of its Design IP busi...

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
GlobeNewswire Inc. • Grabar Law Office • December 30, 2025

Grabar Law Office is investigating shareholder claims against four companies for alleged breaches of fiduciary duties and securities fraud. Cytokinetics faces allegations of misleading statements regarding FDA decisions on its aficamten drug application. Molina Healthcare is accused of failing to disclose adverse medical cost trends and guidance ...

SNPS STOCK NOTICE: Synopsys, Inc. IP Underperformance Leads to Securities Class Action – Contact BFA Law before Tuesday’s December 30 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp • December 27, 2025

A securities class action lawsuit has been filed against Synopsys, Inc. for alleged fraud following a 36% stock price decline on September 10, 2025. The company's Design IP segment, which grew to 31% of revenue by 2024, underperformed expectations due to increased customer customization requirements that deteriorated business economics. Q3 2025 r...

SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc. • The Schall Law Firm • December 26, 2025

The Schall Law Firm is seeking investors who purchased Synopsys securities between December 4, 2024 and September 9, 2025 to join a class action lawsuit alleging securities fraud. The firm claims Synopsys made false and misleading statements regarding its AI customer focus negatively impacting its Design IP business, with certain roadmap and reso...

Related Companies